Tags Kaléo

Tag: Kaléo

Sanofi

Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy

More legal troubles for the embattled marketer of EpiPen.
Kmart

Kmart Announces Lower Price of Adrenaclick Generic

May cost as low as $0 to consumers with commercial health insurance.
Senator Claire McCaskill

Senators Inquire into Kaléo Pricing

Pricing for their Evzio naloxone auto-injector is similar to that of their recently relaunched Auvi-Q epinephrine auto-injector.

Auvi-Q Goes On Sale Today with a Bold Pricing and Distribution Structure

Innovation and participation by insurers will be key to the successful reintroduction of the device.

Auvi-Q and the $4500 Question

Will kaleó succeed in providing an affordable auto-injector alternative to families in desperate need?

Kaleo Takes a Bold Step as Auvi-Q Returns

The company pledges $0 out-of-pocket expenses for many when the auto-injector is reintroduced February 14. FAQ included in article.

The Reliability of Auvi-Q: An Interview with Eric Edwards

We discuss the changes kaléo is making to the manufacture and quality assurance of Auvi-Q prior to its reintroduction in 2017.

Kaléo Press Release: Return of Auvi-Q in 2017

Press release regarding the return of the Auvi-Q epinephrine auto-injector, reprinted here for the convenience of our readers.

Auvi-Q Returning to Market in 2017

Kaleo has announced the device will return to the market in the first half of 2017.

Sanofi Abandons Auvi-Q, Allerject

Whether the product will ever be reintroduced remains to be seen.

Connect with Us

28,281FansLike
84FollowersFollow
3,953FollowersFollow
31SubscribersSubscribe